Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma

被引:212
作者
Jones, Chris [1 ,2 ]
Baker, Suzanne J. [3 ]
机构
[1] Inst Canc Res, Ctr Evolut & Canc, Div Mol Pathol, Sutton SM2 5NG, Surrey, England
[2] Inst Canc Res, Div Canc Therapeut, Sutton SM2 5NG, Surrey, England
[3] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38117 USA
基金
美国国家卫生研究院;
关键词
INTRINSIC PONTINE GLIOMAS; RECEPTOR TYROSINE KINASES; HISTONE H3.3 MUTATIONS; BRAIN-STEM GLIOMA; DRIVER MUTATIONS; GENOMIC LANDSCAPE; CELL; GLIOBLASTOMA; CHILDREN; CANCER;
D O I
10.1038/nrc3811
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffuse high-grade glionnas (HGGs) of childhood are a devastating spectrum of disease with no effective cures. The two-year survival for paediatric HGG ranges from 30%, for tumours arising in the cerebral cortex, to less than 10% for diffuse intrinsic pontine gliomas (DIPGs), which arise in the brainstem. Recent genome-wide studies provided abundant evidence that unique selective pressures drive HGG in children compared to adults, identifying novel oncogenic mutations connecting tunnorigenesis and chromatin regulation, as well as developmental signalling pathways. These new genetic findings give insights into disease pathogenesis and the challenges and opportunities for improving patient survival in these mostly incurable childhood brain tumours.
引用
收藏
页码:651 / 661
页数:11
相关论文
共 99 条
[1]   H3F3A K27M mutations in thalamic gliomas from young adult patients [J].
Aihara, Koki ;
Mukasa, Akitake ;
Gotoh, Kengo ;
Saito, Kuniaki ;
Nagae, Genta ;
Tsuji, Shingo ;
Tatsuno, Kenji ;
Yamamoto, Shogo ;
Takayanagi, Shunsaku ;
Narita, Yoshitaka ;
Shibui, Soichiro ;
Aburatani, Hiroyuki ;
Saito, Nobuhito .
NEURO-ONCOLOGY, 2014, 16 (01) :140-146
[2]  
ALBRIGHT AL, 1993, NEUROSURGERY, V33, P1026
[3]   Post mortem examinations in diffuse intrinsic pontine glioma: challenges and chances [J].
Angelini, Paola ;
Hawkins, Cynthia ;
Laperriere, Normand ;
Bouffet, Eric ;
Bartels, Ute .
JOURNAL OF NEURO-ONCOLOGY, 2011, 101 (01) :75-81
[4]   Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation [J].
Bagarova, Jana ;
Vonner, Ashley J. ;
Armstrong, Kelli A. ;
Boergermann, Jan ;
Lai, Carol S. C. ;
Deng, Donna Y. ;
Beppu, Hideyuki ;
Alfano, Ivan ;
Filippakopoulos, Panagis ;
Morrell, Nicholas W. ;
Bullock, Alex N. ;
Knaus, Petra ;
Mishina, Yuji ;
Yu, Paul B. .
MOLECULAR AND CELLULAR BIOLOGY, 2013, 33 (12) :2413-2424
[5]   Bereaved Parents' Intentions and Suggestions about Research Autopsies in Children with Lethal Brain Tumors [J].
Baker, Justin Nathaniel ;
Windham, Jennifer A. ;
Hinds, Pamela S. ;
Gattuso, Jami S. ;
Mandrell, Belinda ;
Gajjar, Poorna ;
West, Nancy K. ;
Hammarback, Teresa ;
Broniscer, Alberto .
JOURNAL OF PEDIATRICS, 2013, 163 (02) :581-586
[6]  
Ballester LY, 2013, AM J SURG PATHOL, V37, P1357, DOI 10.1097/PAS.0b013e318294e817
[7]   New Strategies in Neuroblastoma: Therapeutic Targeting of MYCN and ALK [J].
Barone, Giuseppe ;
Anderson, John ;
Pearson, Andrew D. J. ;
Petrie, Kevin ;
Chesler, Louis .
CLINICAL CANCER RESEARCH, 2013, 19 (21) :5814-5821
[8]   Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas [J].
Barrow, Jennifer ;
Adamowicz-Brice, Martyna ;
Cartmill, Maria ;
MacArthur, Donald ;
Lowe, James ;
Robson, Keith ;
Brundler, Marie-Anne ;
Walker, David A. ;
Coyle, Beth ;
Grundy, Richard .
NEURO-ONCOLOGY, 2011, 13 (02) :212-222
[9]   PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma [J].
Barton, Kelly L. ;
Misuraca, Katherine ;
Cordero, Francisco ;
Dobrikova, Elena ;
Min, Hooney D. ;
Gromeier, Matthias ;
Kirsch, David G. ;
Becher, Oren J. .
PLOS ONE, 2013, 8 (10)
[10]   Vemurafenib in Pediatric Patients With BRAFV600E Mutated High-Grade Gliomas [J].
Bautista, Francisco ;
Paci, Angelo ;
Minard-Colin, Veronique ;
Dufour, Christelle ;
Grill, Jacques ;
Lacroix, Ludovic ;
Varlet, Pascale ;
Valteau-Couanet, Dominique ;
Geoerger, Birgit .
PEDIATRIC BLOOD & CANCER, 2014, 61 (06) :1101-1103